Bifogade filer
Kurs & Likviditet
Kalender
2024-11-15 | Kvartalsrapport 2024-Q3 |
2024-08-30 | Kvartalsrapport 2024-Q2 |
2024-05-17 | Ordinarie utdelning KDEV 0.00 SEK |
2024-05-16 | Årsstämma 2024 |
2024-04-26 | Kvartalsrapport 2024-Q1 |
2024-02-16 | Bokslutskommuniké 2023 |
2023-11-17 | Kvartalsrapport 2023-Q3 |
2023-08-25 | Kvartalsrapport 2023-Q2 |
2023-05-17 | Ordinarie utdelning KDEV 0.00 SEK |
2023-05-16 | Årsstämma 2023 |
2023-04-28 | Kvartalsrapport 2023-Q1 |
2023-02-17 | Bokslutskommuniké 2022 |
2022-11-18 | Kvartalsrapport 2022-Q3 |
2022-08-19 | Kvartalsrapport 2022-Q2 |
2022-05-13 | Ordinarie utdelning KDEV 0.00 SEK |
2022-05-12 | Årsstämma 2022 |
2022-04-29 | Kvartalsrapport 2022-Q1 |
2022-02-25 | Bokslutskommuniké 2021 |
2022-01-12 | Extra Bolagsstämma 2022 |
2021-11-18 | Kvartalsrapport 2021-Q3 |
2021-08-19 | Kvartalsrapport 2021-Q2 |
2021-05-06 | Ordinarie utdelning KDEV 0.00 SEK |
2021-05-05 | Årsstämma 2021 |
2021-04-29 | Kvartalsrapport 2021-Q1 |
2021-02-19 | Extra Bolagsstämma 2021 |
2021-02-11 | Bokslutskommuniké 2020 |
2020-11-11 | Kvartalsrapport 2020-Q3 |
2020-08-20 | Kvartalsrapport 2020-Q2 |
2020-06-16 | Ordinarie utdelning KDEV 0.00 SEK |
2020-06-15 | Årsstämma 2020 |
2020-04-30 | Kvartalsrapport 2020-Q1 |
2020-02-13 | Bokslutskommuniké 2019 |
2019-11-29 | Kvartalsrapport 2019-Q3 |
2019-08-30 | Kvartalsrapport 2019-Q2 |
2019-06-28 | Årsstämma 2019 |
2019-05-21 | Kvartalsrapport 2019-Q1 |
2019-05-08 | Ordinarie utdelning KDEV 0.00 SEK |
2019-02-14 | Bokslutskommuniké 2018 |
2018-10-31 | Kvartalsrapport 2018-Q3 |
2018-08-16 | Kvartalsrapport 2018-Q2 |
2018-04-27 | Ordinarie utdelning KDEV 0.00 SEK |
2018-04-26 | Årsstämma 2018 |
2018-04-25 | Kvartalsrapport 2018-Q1 |
2018-02-15 | Bokslutskommuniké 2017 |
2017-10-31 | Kvartalsrapport 2017-Q3 |
2017-08-29 | Kvartalsrapport 2017-Q2 |
2017-05-26 | Ordinarie utdelning KDEV 0.00 SEK |
2017-05-24 | Årsstämma 2017 |
2017-05-16 | Kvartalsrapport 2017-Q1 |
2017-02-28 | Bokslutskommuniké 2016 |
2016-11-23 | Kvartalsrapport 2016-Q3 |
2016-08-31 | Kvartalsrapport 2016-Q2 |
2016-05-26 | Ordinarie utdelning KDEV 0.00 SEK |
2016-05-25 | Årsstämma 2016 |
2016-05-10 | Kvartalsrapport 2016-Q1 |
2016-02-23 | Bokslutskommuniké 2015 |
2015-11-17 | Kvartalsrapport 2015-Q3 |
2015-08-26 | Kvartalsrapport 2015-Q2 |
2015-05-21 | Ordinarie utdelning KDEV 0.00 SEK |
2015-05-20 | Årsstämma 2015 |
2015-05-06 | Kvartalsrapport 2015-Q1 |
2015-02-18 | Bokslutskommuniké 2014 |
2014-12-04 | Extra Bolagsstämma 2014 |
2014-10-21 | Analytiker möte 2014 |
2014-10-21 | Kapitalmarknadsdag 2014 |
2014-10-21 | Kvartalsrapport 2014-Q3 |
2014-08-21 | Kvartalsrapport 2014-Q2 |
2014-05-15 | Ordinarie utdelning KDEV 0.00 SEK |
2014-05-14 | Årsstämma 2014 |
2014-05-08 | Kvartalsrapport 2014-Q1 |
2014-02-19 | Bokslutskommuniké 2013 |
2013-11-21 | Kvartalsrapport 2013-Q3 |
2013-11-21 | Analytiker möte 2013 |
2013-08-22 | Kvartalsrapport 2013-Q2 |
2013-05-15 | Ordinarie utdelning KDEV 0.00 SEK |
2013-05-14 | Årsstämma 2013 |
2013-05-10 | Kvartalsrapport 2013-Q1 |
2013-03-20 | Bokslutskommuniké 2012 |
2013-03-20 | Extra Bolagsstämma 2013 |
2013-03-13 | 15-7 2013 |
2012-11-22 | Analytiker möte 2012 |
2012-11-22 | Kvartalsrapport 2012-Q3 |
2012-08-23 | Kvartalsrapport 2012-Q2 |
2012-05-24 | Ordinarie utdelning KDEV 0.00 SEK |
2012-05-23 | Årsstämma 2012 |
2012-05-15 | Kvartalsrapport 2012-Q1 |
2012-02-22 | Bokslutskommuniké 2011 |
2011-11-29 | 15-7 2011 |
2011-11-25 | Kvartalsrapport 2011-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Finans |
Industri | Investeringar |
STOCKHOLM – March 16, 2020. Due to COVID-19, Karolinska Development has postponed the date for the Annual General Meeting from May 7 to June 15, 2020. Notice to the Annual General Meeting will be published in a separate press release.
For further information, please contact:
Viktor Drvota, CEO, Karolinska Development AB
Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com
Ulf Richenberg, General Counsel, Karolinska Development AB
Phone: +46 70 29 860 25, e-mail: ulf.richenberg@karolinskadevelopment.com
TO THE EDITORS
About Karolinska Development AB
Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investment company. The company focuses on identifying breakthrough medical innovations in the Nordic region that are developed by entrepreneurs and leadership teams. The Company invests in the creation and growth of companies that advance these assets into commercial products that are designed to make a difference to patients' lives while providing an attractive return on investment to shareholders.
Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success.
Karolinska Development has established a portfolio of nine companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.
The Company is led by an entrepreneurial team of investment professionals with a proven track record as company builders and with access to a strong global network.
For more information, please visit www.karolinskadevelopment.com